CJC-1295 W/O DAC 5/10mg

CJC-1295 W/O DAC 5/10mg
£30.00

(NOT FOR HUMAN CONSUMPTION RESEARCH USE ONLY) 

CJC-1295 no DAC

(Drug Affinity Complex), also known as Modified GRF (1-29) or Mod GRF, is a synthetic peptide that mimics a naturally occurring growth hormone-releasing hormone (GHRH) to stimulate the pituitary gland. Unlike its long-acting "with DAC" counterpart, it has a very short half-life, which produces a more natural, pulsatile release of growth hormone. 

 

Core Function and Mechanism

CJC-1295 no DAC is essentially a modified form of Sermorelin (GRF 1-29) engineered for slightly better stability during manufacturing and transport. 

  • Pulsatile GH Release: It works by binding to GHRH receptors in the pituitary gland, triggering a rapid release of stored growth hormone (GH) in a manner that closely mimics the body's natural circadian rhythm.
  • Short Half-Life: Its half-life is approximately 30 minutes, meaning it is quickly metabolized and eliminated from the body. This rapid action prevents the constant elevation of GH levels that can lead to receptor desensitization over time.
  • Synergy with Ipamorelin: It is often used in combination with Ipamorelin, a GH secretagogue, to maximize the release of GH through two different receptor pathways. 

 

Potential Benefits

By increasing growth hormone and insulin-like growth factor 1 (IGF-1) levels, the peptide is associated with several benefits observed in research and anecdotal reports:

  • Enhanced Muscle Growth: Fosters muscle hypertrophy (growth) and increases muscle protein synthesis.
  • Fat Loss: Improves the body's ability to burn fat by increasing lipolysis (fat breakdown) and metabolic rate.
  • Improved Recovery: Accelerates healing from injuries and exercise, supporting tissue, joint, and nerve regeneration.
  • Better Sleep Quality: Helps facilitate deeper, more restorative slow-wave sleep, which is when the body produces the most natural GH.
  • Anti-Aging Effects: May improve skin elasticity, strengthen the immune system, and enhance cognitive function. 

 

Safety and Regulatory Status

CJC-1295 no DAC is an investigational compound with no formal medical approval.

  • FDA Status: It is not approved for human medical use by the FDA. It is legally sold as a "research chemical" intended for in vitro (laboratory) studies only, not for human consumption.
  • WADA Status: It is a prohibited substance under the World Anti-Doping Agency (WADA) Prohibited List.
  • Side Effects: Common side effects are generally mild and transient due to the short half-life. They often include a warm, flushed feeling or headache immediately after injection, as well as potential injection site reactions (pain, redness, swelling). 

Warning: The use of CJC-1295 no DAC without medical supervision is not recommended due to the lack of long-term human safety data and potential risks.